You points around MS letting others do the R&D to support them...

First 41 Last

Share
Profile

Follow
Jim55M

100 Posts.

3

13/08/18

19:16

Post #: 34908249
Share

Originally posted by e7dem ↑

What value is there for Microsoft to take a position in LVT, or takeover for that matter? Probably very little.

There's probably a reason Microsoft has gone down the path of partnering with hundreds of small up and coming R&D firms building on MS platforms. I think that is the value for Microsoft, to minimize their own R&D and to partner with the best and most innovative. That's a great way to create value for Microsoft, minimize R&D cost and get fierce competition amongst thousands of smaller players developing features and products on MS platform. Plus, it minimizers the risk of Microsoft sinking heavy R&D dollars and getting it wrong.

Now what does this say about LVT? They must be ahead and be doing a damn fine job by getting so much attention and so many awards from Microsoft. What will this translate to? Well, I think we're seeing it in super growth and more and bigger sales.

The SP? I think it's attractive at the moment. But I think the market players have captured a golden opportunity to play with retail investors who are a big part of the register at the moment. Not sure if 59c will be the floor, it all depends on how the market makers decide to play this over the next couple of months (not weeks, but months). I'm giving it a strong buy, but uncertain where bargain territory is.

Expand

You points around MS letting others do the R&D to support them is insightful IMO.
There is no case for MS T/O they do not need to spend much to get most of the benefit with zero risk. If only investing were that easy!!

LVT Price at posting: 62.5¢ Sentiment: Hold Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ASX Market Open: Futures say drop after Bullock's hawkish speech removes slow cut doubts | Nov 29, 2024

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

There are more pages in this discussion • 6 more messages in this thread...

First 41 Last

Add LVT (ASX) to my watchlist

You points around MS letting others do the R&D to support them...

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

ASX Market Open: Futures say drop after Bullock's hawkish speech removes slow cut doubts | Nov 29, 2024

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects